Compare Duke Energy Corp (DUK) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Duke Energy Corp vs Natera Inc. Common Stock — how do they compare? Duke Energy Corp trades at $120.92 (market cap $92.15B), while Natera Inc. Common Stock trades at $393.27 (market cap $57.03B). The key difference: Duke Energy Corp is the larger of the two by market cap, and Duke Energy Corp pays a 3.67% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Duke Energy Corp for 75 Days and Natera Inc. Common Stock for 0 Days on average.
| DUK | NTRA | |
|---|---|---|
Market Cap | $92.15B | $57.03B |
Volume | 3,498,824 | 1,131,157 |
Sector | Utilities | Health |
52-Week High | $133.46 | $425.64 |
52-Week Low | $113.23 | $179.42 |
Typical Hold Time | 75 Days | 0 Days |
Enterprise Value | $184.66B | $56.18B |
Dividend Yield | 3.67% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Duke Energy (DUK) trades at $119.64, up 1.66% on the day, with a bullish technical signal despite some overbought RSI readings. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Revenue and net income have grown steadily, reaching $32.24B and $4.97B in 2025, respectively, while maintaining strong profitability margins. Recent news highlights dividend declarations and data center growth opportunities.
The outlook for DUK is positive, supported by consistent earnings beats, a solid dividend yield, and strategic positioning in data center contracts. Risks include high debt levels, rising interest rates impacting utility stocks, and execution challenges in capital-intensive projects. Analyst consensus leans hold with a $131.50 price target, suggesting moderate upside from current levels.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Duke Energy Corp
Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure
Read more on DUK →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
